Mast Therapeutics, Inc. (MSTX)

[daddybird292]

I think it's a race at this point.

PR's are good and all - but their effect is fleeting.
It would bring huge swings to the PPS (both up and down) - I could live with that :)
We wouldn't want people to get numb to PR's though - the actual event would be lessened.

No, ANX needs product. Our product is the potential for a drug or two - not the drug itself.

Why? Because we can't fix or improve the drug. Not enough money, time or manpower.

So, it's the perception of threat against big pharma that's key.
That's NDA's, FDA accepts, and partnerships - not the drug itself.

Weird isn't it?

At the same time - I wouldn't be surprised for the PPS to be brought into the low teens several times over the next few months so Icahn and Craimer can grab a majority stake of the commons as the VOL goes down, buyers tire, and the axe gets agressive...

But yes, Genzym eats ANX and becomes a superpower overnight - and Icahn will own Genzym - probably exchanging ANX shares for Genzym shares to bump him over 51% (if he isn't there already by that time).


-DB